These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33041448)

  • 1. Investigating Cervical Risk Factors that Lead to Cytological and Biopsy Examination.
    Sindiani AM; Alshdaifat EH; Alkhatib AJ
    Med Arch; 2020 Aug; 74(4):294-297. PubMed ID: 33041448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
    Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
    BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can women at risk of cervical abnormality be identified?
    Blomfield PI; Lancashire RJ; Woodman CB
    Br J Obstet Gynaecol; 1998 May; 105(5):486-92. PubMed ID: 9637116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
    ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
    Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study.
    Roura E; Iftner T; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; Rodriguez MS; Morillo C; Serradell L; Torcel-Pagnon L; Cortes J; Castellsagué X;
    BMC Infect Dis; 2012 Jun; 12():145. PubMed ID: 22734435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based statistical analysis for early stage detection of cervical cancer.
    Ali MM; Ahmed K; Bui FM; Paul BK; Ibrahim SM; Quinn JMW; Moni MA
    Comput Biol Med; 2021 Dec; 139():104985. PubMed ID: 34735942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
    Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
    Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between HIV infection and cervical intraepithelial neoplasia among women attending two family planning clinics in Nairobi, Kenya.
    Maggwa BN; Hunter DJ; Mbugua S; Tukei P; Mati JK
    AIDS; 1993 May; 7(5):733-8. PubMed ID: 8318180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjogren's syndrome.
    Cirpan T; Guliyeva A; Onder G; Terek MC; Ozsaran A; Kabasakal Y; Zekioglu O; Yucebilgin S
    Eur J Gynaecol Oncol; 2007; 28(4):302-6. PubMed ID: 17713098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in biologic maturation, sexual behavior, and sexually transmitted disease between adolescents with and without cervical intraepithelial neoplasia.
    Moscicki AB; Winkler B; Irwin CE; Schachter J
    J Pediatr; 1989 Sep; 115(3):487-93. PubMed ID: 2769512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HPV cervical infection in a family planning clinic determined by polymerase chain reaction and dot blot hybridisation.
    Hallam N; Green J; Gibson P; Powis J; Bibby J
    J Med Virol; 1991 Jul; 34(3):154-8. PubMed ID: 1919537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
    Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study.
    Tay SK; Oon LL
    Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical cancer screening: past--present--future].
    Breitenecker G
    Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
    Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
    Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cervical cancer in Colombia and Spain.
    Bosch FX; Muñoz N; de Sanjosé S; Izarzugaza I; Gili M; Viladiu P; Tormo MJ; Moreo P; Ascunce N; Gonzalez LC
    Int J Cancer; 1992 Nov; 52(5):750-8. PubMed ID: 1330934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.